About Stryker Corporation
Stryker Corporation (SYK) is a Healthcare company in the Surgical & Medical Instruments & Apparatus industry with a market capitalisation of $106.3B. The stock trades at 28.55x trailing earnings and yields 1.28%.
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments & Apparatus
- Market cap
- $106.3B
- P/E ratio
- 28.55
- EPS (TTM)
- $8.40
- Revenue (TTM)
- $25.1B
- Free cash flow
- $4.3B
- Profit margin
- 12.9%
- Dividend yield
- 1.28%
- Shares outstanding
- 383.6M
Financial health: Strong9/10
8 strengths, 0 concerns. No red flags against these benchmarks.
- Debt to equity: 0.71 (Watch, benchmark < 0.5) — Debt of 0.71x equity is moderate against the 0.5x benchmark. It has been broadly flat over the last 4 years.
- Net debt vs cash flow: 2.7y (Strong, benchmark < 4 years) — Net debt of $11.8B is 2.7x annual free cash flow — about 3 years of cash flow to repay.
- Current ratio: 1.89 (Strong, benchmark > 1.5) — Short-term assets cover 1.89x short-term liabilities, against Graham's 1.5x floor. It has improved over the last 4 years.
- Return on equity: 27.7% (Strong, benchmark > 15%) — Earns 27.7% on shareholder equity, comfortably past the > 15% mark.
- Gross margin: 64.0% (Strong, benchmark > 40%) — Keeps 64.0% of revenue after the direct cost of sales, comfortably past the > 40% mark.
- Net margin: 12.9% (Strong, benchmark > 10%) — Turns 12.9% of revenue into profit, comfortably past the > 10% mark.
- Free cash flow: $4.3B (Strong, benchmark positive) — Generated $4.3B of free cash flow after capital spending. It has improved over the last 4 years.
- Revenue growth: 11.2% (Strong, benchmark > 10%) — Revenue changed 11.2% year on year, comfortably past the > 10% mark.
- Earnings growth: 8.5% (Watch, benchmark > 10%) — Earnings changed 8.5% year on year, short of the > 10% mark.
- Payout ratio: 39.6% (Strong, benchmark < 60%) — Pays out 39.6% of earnings as dividends, leaving room to keep paying.